Apoptotic death of tumor cells correlates with chemosensitivity, independent of p53 or Bcl-2

Clinical Cancer Research

Volumn 2, Issue 4, 1996, Pages 623-633

  Wu, Gen Sheng ^a   El Deiry, Wafik S ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; PROTEIN BCL 2; PROTEIN P53;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG SENSITIVITY; HUMAN; HUMAN CELL; LEUKEMIA CELL; LYMPHOMA CELL; PRIORITY JOURNAL; TUMOR CELL LINE;

APOPTOSIS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DNA FRAGMENTATION; DRUG RESISTANCE, NEOPLASM; HUMANS; NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0029928561     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. DeVita, V.T. Principles of chemotherapy, In: V. T. DeVita, S. Hellman, and S. A. Rosenberg (eds,), Cancer: Principles and Practice of Oncology, 3rd ed., pp. 276-300. Philadelphia: J. B. Lippincott Co., 1989.
2. Fojo, A. T., Whang-Peng, J., Gottesman, M. M., and Pastan, I. Amplification of DNA sequences in human multidrug resistant KB carcinoma cells. Proc. Natl Acad. Sci. USA, 82: 7661-7665, 1985.
3. Nunez, G., London, L., Hockenbery, D., Alexander. M., McKearn, J. P., and Korsmeyer, S. J. Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hematopoietic cell lines. J. Immunot., 144: 3602-3610, 1990.
4. 2-M transition after DKA damage: a mechanism of resistance to multiple anticancer agents. Blood, 86: 1148-1158, 1995.
5. Kondo, S., Barnett, G. H., Hara, H., Morimura, T., and Tekeuchi, J. MDM2 protein confers the resistance of a human glioblastoma cell line to cisplatin-induced apoptosis. Oncogene, 10: 2001-2006, 1995.
6. Potmesil, M., Hsiang, Y. H., Liu, L. F., Wu, H. Y., Traganos, F., Bank, B., and Silber, R. DNA topoisomerase II as a potential factor in drug resistance of human malignancies. Natl. Cancer Inst. Monogr., 4, 105-109, 1987.
7. Fan, S., El-Deiry, W. S., Bae, L, Freeman, J., Jondle, D., Bhatia, K., Fornace, A. J., Jr., Magrath, I., Kohn, K. W., and O'Connor, P. M. p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA-damaging agents. Cancer Res., 54: 5824-5830, 1994.
8. Clarke, A. R., Purdie, C. A., Harrison, D. J., Morris, R. G., Bird, C. C., Hooper, M. L., and Wyllie, A. H. Thyrnocyte apoptosis induced by p53-dependent and independent pathways. Nature (Lond.), 362: 849-852, 1993
9. Lowe, S. W., Schmitt, E. M., Smith, S. W., Osborne, B. A., and Jacks, T. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature (Lond.), 362: 847-849, 1993.
10. Lowe, S. W., Ruley, H. E., Jacks, T., and Housman, D. E. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell. 74:957-967, 1993.
11. Lowe, S. W., Bodis, S., McClatchey, A., Remington, L., Ruley, H. E., Fisher, D, E., Housman, D. E., and Jacks, T. p53 status and the efficacy of cancer therapy in vivo Science (Washington DC), 266: 807-810, 1994.
12. Symonds, H., Krall, L., Remington, L., Saenz-Robles, M., Lowe, S., Jacks, T., and Van Dyke, T. p53-dependent apoptosis suppresses tumor growth and progression in vivo. Cell. 78: 703-711, 1994.
13. Tsang, N-M., Nagasawa, H., Li, C., and Little, J. B. Abrogation of p53 function by transfection of HPV16 E6 gene enhances the resistance of human diploid fibroblasts to ionizing radiation. Oncogene, 10: 2403-2408, 1995.
14. 1 arrest and apoptosis. Cancer Res., 54: 1169-1174, 1994.
15. WAF1/CIP1 expression in normal and neoplastic tissues. Cancer Res., 55: 2910-2919, 1995.
16. Crissman, H. A., and Hirons, G. T. Staining of DNA in live and fixed cells. Methods Cell Biol., 41: 197-198, 1994.
17. Arends, M. J., Morris, R. G., and Wyllie, A. H Apoptosis: the role of the endonuclease. Am. J. Pathol., 136: 593-608, 1990.
18. Borner, M. M., Myers, C. E., Sartor, O , Sei, Y., Toko, T., Trepel, J. B., and Schneider. E. Drug-induced apoptosis is not necessarily dependent on macromolecular synthesis or proliferation in the p53-negative human prostate cancer cell line PC-3. Cancer Res., 55: 2122-2128, 1995.
19. El-Deiry, W. S., Tokino, T., Velcufescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E. Kinzler, K. W., and Vogelstein, B. WAF1. a potential mediator of p53 tumor suppression. Cell. 75: 817-825, 1993.
20. Baker, S. J., Markowitz, S., Fearon, E. R., Willson, J. K. V., and Vogelstein. B. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science (Washington DC), 249: 912-915, 1990.
21. Kastan, M. B., Onyerkwere, O., Sidransky, D., Vogeistein, B., and Craig, R. W. Participation of p53 protein in the cellular response to DNA damage. Cancer Res., 53: 6304-6311, 1991.
22. Yaginuma, Y., and Westphal, H. Abnormal structure and expression of the p53 gene in human ovarian carcinoma cell lines. Cancer Res., 52: 4196-4199, 1992.
23. Kern, S. E., Pietenpol, J. A., Thiagalingam, S., Seymour, A., Kinzler, K. W., and Vogelstein, B. Oncogenic forms of p53 inhibit p53-regulated gene expression. Science (Washington DC), 256: 827-830, 1992.
24. Thompson, C. B. Apoptosis in the pathogenesis and treatment of disease. Science (Washington DC), 267: 1456-1462, 1995.
25. Fisher, D. E. Apoptosis in cancer therapy: crossing the threshold. Cell, 78: 539-542, 1994.
26. Hockenbery, D., Nunez, G., Milliman, C., Schreiber, R. D., and Korsmeyer, S. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature (Lond.), 348: 334-336, 1990.
27. Fanidi, A., Harrington, E. A., and Evan, G. Cooperative interaction between c-myc and bcl-2 proto-oncogenes. Nature (Lond.), 359: 554-556, 1992.
28. White, E., Grodzicker, T., and Stillman, B. W. Mutations in the gene encoding the adenovirus E1B 19K tumor antigen cause degradation of chromosomal DNA. J. Virol., 52: 410-419, 1984.
29. Debbas, M., and White, E. Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. Genes & Dev., 7: 546-554, 1993.
30. Yonisch-Rouach, E., Resnitzky, D., Lotem, J , Sachs, L., Kimchi, A., and Oren, M Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature (Lond.), 352: 345-347, 1991.
31. Wang, Y., Szekely, L., Okan, I., Klein, G., and Wiman, K. G. Wild-type p53-triggered apoptosis is inhibited by bcl-2 in a v-myc-induced T-cell lymphoma line. Oncogene, 8: 3427-3431, 1993
32. Rao, L., Debbas, M., Sabbatini, P., Hockenbery, D., Korsmeyer, S., and White, E. The adenovirus E1A proteins induce apoptosis which is inhibited by the E1B 19K and Bcl-2 proteins. Proc. Natl. Acad. Sci. USA, 89: 7742-7746, 1992.
33. Whyte, M , and Evan, G. The last cut is the deepest. Nature (Lond.), 376: 17-18, 1995.
34. Martin, S. J., and Green, D. R. Protease activation during apoptosis: death by a thousand cuts? Cell, 82: 349-352, 1995.
35. Owen-Schaub, L. B., Zhang, W., Cusack, J. C., Angelo, L. S., Santee, S. M., Fujiwara, T., Roth, J. A., Deisseroth, A. B., Zhang, W-W., Kruzel, E., and Radinsky, R Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression Mol. Cell. Biol., 15; 3032-3040, 1995.
36. Miyashita, T., Krajewski, S., Krajewski, M., Wang, H. G., Lin, H. K , Huffman, B., Lieberman, D., and Red, J. C. Tumor suppressor p53 is a regulator of bell and bax in gene expression in vitro and in vivo. Oncogene, 9: 1799-1805, 1994.
37. Miyashita, T., and Reed, J. C. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell, 80: 293-299, 1995
38. Zhan, Q., Fan, S., Bae, I., Guillouf, C., Lieberman, D. A., O'Connor, P. M., and Fornace, A. J., Jr. Induction of bax by genotoxic stress in human cells correlates with normal p53 status and apoptosis. Oncogene. 9: 3743-3751, 1994.
39. 1 checkpoint does not decrease cell survival following DNA damage. Cancer Res . 53: 4164-4168, 1993
40. Fan, S., Smith, M. L., Rivet, DJ., II. Duba, D, Zhan, Q., Kohn, K. W., Fomace, A. J., Jr., and O'Connor, P. M. Disruption of p53 function sensitizes breast cancer MCF-7 cells to cisplatin and pentoxifyline. Cancer Res., 55: 1649-1654, 1995.
41. Tsang, N-M., Nagasawa, H., Li, C., and Little, J. B. Abrogation of p53 function by transfection of HPV 16 E6 gene enhances the resistance of human diploid fibroblasts to ionizing radiation Oncogene. 10: 2403-2408, 1995.
42. Xu, C., Meikrantz, W., Schlegel, R., and Sager, R. The human papilloma virus 16E6 gene sensitizes human mammary epithelial cells to apoptosis induced by DNA damage. Proc Natl. Acad. Sci. USA, 92: 7829-7833, 1995.
43. Bracey, T. S., Miller, J. C., and Paraskeva, C. γ-Radiation-induced apoptosis in human colorectal adenoma and carcinoma cell lines can occur in the absence of wild type p53. Oncogene, 10: 2391-2396, 1995.
44. Kaufmann, S. H. Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide. camptothecin. and other cytotoxic anticancer drugs: a cautionary note. Cancer Res., 49: 5870-5878, 1989.
45. Kastan, M. B., Zhan, Q., El-Deiry, W. S , Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B, and Fornace, A. J., Jr. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell, 71, 587-597, 1992.
46. Wales, M. M., Biel, M A., El-Deiry, W., Nelkin, B. D., Issa, J-P., Cavenee, W K., Kuerbitz, S. J., and Baylin, S. B. p53 activates expression of HIC1. a new candidate tumour suppressor gene on 17p13.3. Nat. Med., I: 570-577, 1995.